Healthpeak Properties (DOC) Q3 2025 10-Q Quarterly Report
Healthpeak Properties (DOC) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Oct 24, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
Healthpeak Properties Q3 2025 10-Q Analysis
Management Discussion & Analysis
- • Net cash from operating activities $958M, up $171M YoY from $787M for nine months ended Sep 30, driven by merger synergies and rent increases
- • Net cash used in investing activities $629M, up $749M YoY due to fewer real estate sales, and more development and acquisitions
Risk Factors
- • Newly added risk: Other-than-temporary impairment charges on two lab unconsolidated joint ventures in 2025 impacting net income
- • Updated financial risk: Increased interest expense from $500M 5.38% senior notes due 2035 and $500M 4.75% notes due 2033 issued in 2025
Healthpeak Properties Q3 2025 Quarterly FinancialsXBRL
Revenue
$150M
▲ +5.3% YoY▲ +1.1% QoQ
Net Income
-$117M
▼ -236.4% YoY▼ -469.8% QoQ
Net Margin
-77.8%
▼ -13796bp YoY▼ -9912bp QoQ
ROE
-1.5%
Total Assets
$19.6B
EPS (Diluted)
$-0.17
▼ -230.8% YoY▼ -440.0% QoQ
Operating Cash Flow
$315M
▼ -1.0% YoY▼ -13.3% QoQ
Source: XBRL data from Healthpeak Properties Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Other Healthpeak Properties Quarterly Reports
Get deeper insights on Healthpeak Properties
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.